Boops Pets vs Arterra Pet Science for Dogs: Which Senior Supplement Actually Fits Your Dog?

By Greg Todd, DVM, CVA

✓ Medically reviewed by Greg Todd, DVM, CVA — August 25, 2026 For general education — not a substitute for veterinary care.

Senior & longevity · August 19, 2026 · 5 min read

If your dog needs one thing done well, Boops wins that fight; if your dog needs a lot of small things covered at once, Arterra earns the nod, and I'll tell you exactly why.

The fork you’re actually standing at

Two supplements, two different jobs. Boops Pets Longevity & Healthy Aging is built around one pathway — NAD+ precursor support — and stays narrow on purpose. Arterra Pet Science’s Adult Longevity Multivitamin Soft Chew goes the other direction: dozens of actives spread across joints, gut, brain, and skin in a single chew. Neither approach is wrong. They’re answers to different questions, and the question your dog is asking depends on what’s actually going on with her.

I’ve had this conversation more times than I can count at the exam table. A twelve-year-old spaniel comes in stiff in the mornings, a little foggier than she used to be, coat slightly duller — nothing acute, nothing that needs a workup this week, just the slow accumulation of “getting old.” The owner wants to do something proactive but doesn’t want six different bottles on the counter. That’s the Arterra conversation: broad coverage, one chew, reasonable per-day cost. Then there’s the dog whose owner has already been reading about NAD+ decline and wants to target that pathway specifically, maybe alongside acupuncture and a conventional senior panel — that’s the Boops conversation. I pair the workup with whatever modality actually answers the question the bloodwork raised, and for a lot of dogs that means picking a lane instead of a shotgun.

What each one is actually built to do

Boops Pets Longevity & Healthy Aging delivers Nicotinamide Riboside at 120 mg per two-chew serving alongside quercetin (100 mg), resveratrol (40 mg), vitamin C (100 mg), and niacinamide (50 mg). Nicotinamide Riboside is a NAD+ precursor that supports normal cellular function, and NAD+ levels decline with age — NR helps the body make the NAD+ used in everyday cellular energy metabolism, per Boops’ vet-reviewed claim list. Resveratrol and quercetin are positioned as the antioxidant supporting cast: Resveratrol (40 mg) and quercetin (100 mg) are antioxidants that support cellular health and vitality.

Arterra Pet Science takes the opposite bet. Their Adult Longevity Multivitamin Soft Chew, per their Arterra Pet Science product page, packs 39 clinically studied ingredients at roughly 50% active content, spanning berberine, collagen, quercetin, turmeric, taurine, CoQ10, and green tea extract — a multivitamin approach rather than a single-pathway one. Notably, Arterra’s longevity formulation leans on NAD-adjacent actives like PQQ and quercetin rather than a direct NAD+ precursor such as nicotinamide riboside or NMN. If NAD+ repletion specifically is what you’re after, that’s a real gap on their side of the ledger.

Where Arterra genuinely wins

This is the part I won’t fudge: on breadth-per-chew and shelf price, Arterra has the real edge. Their 60-count chews start around $1.00 each, dropping to about $0.58 with a 120-count subscription — a lower per-day cost than most single-pathway longevity chews, Boops included. And if a dog’s issue list reads “joints, gut, coat, a little brain fog,” one Arterra chew is genuinely covering more ground than pairing several targeted products would. That’s the honest use case Arterra owns: the dog who needs general senior-wellness coverage, not a targeted NAD+ push, and the owner who wants one supplement instead of a rotating cabinet.

Where Boops holds its ground

Boops isn’t trying to be everything. It’s a NAD+ precursor formula, dosed transparently (120 mg NR per two-chew serving, disclosed down to the milligram), made in an FDA-registered, GMP-compliant US facility, and Boops Pets is a NASC Primary Supplier Member carrying the NASC Quality Seal — independently audited facilities, not a self-reported claim. The product is also independently third-party (Eurofins) tested for purity and potency. In an owner survey, March 2025, n=193 (independent third party), 97.8% of owners reported visible improvement after the first jar, with 94% reporting cognitive-function changes and 98% reporting energy changes — owner-reported experience, not a clinical trial, but a real dataset with a disclosed methodology. Arterra publishes ingredient counts and percentages; it does not publish an equivalent independently-conducted owner outcome survey.

For the dog whose primary concern is cellular aging and energy specifically — the one where you’ve already ruled out joint disease and GI issues on a workup — Boops is the more targeted tool. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.

A case that made the distinction click for me

A client brought in her ten-year-old Lab mix, Duchess, sixty-eight pounds, last winter. Nothing alarming — just slower on the stairs, sleeping later into the morning, less interested in the second walk. Bloodwork and joint exam came back essentially clean for her age; no arthritis, no organ values out of range. The owner had already tried a joint chew because that’s what the internet told her to buy, and Duchess’s stairs were no better three months in, because stairs weren’t the problem — there was nothing structurally wrong to fix. What she was describing sounded more like general energy and alertness drift than joint pain. We talked about narrowing the target instead of adding another broad product, and she switched to a single-pathway NAD+ chew alongside her existing senior wellness routine. By the six-week recheck she said Duchess was initiating the evening walk again, which is anecdotal — one dog, one owner’s observation — but it’s exactly the kind of case where matching the supplement to the actual gap in the workup mattered more than ingredient count on the label.

If your dog’s issue looks like Duchess’s — a workup that comes back clean but an owner who’s still watching something slip — read our guide on the best longevity supplement for senior dogs or go deeper on NAD+ supplement picks before deciding. If instead the issue is mobility or a stumble that looks neurologic rather than metabolic, don’t reach for either of these first — start with why a dog’s back legs give out or the hind-leg-weakness checklist to rule out spinal disease.

The short version

Arterra wins on price-per-day and ingredient breadth if your dog needs general senior coverage across joints, gut, and coat in one chew. Boops wins if the goal is targeted NAD+ precursor support with a disclosed dose, NASC Quality Seal membership, third-party purity testing, and a transparent owner-survey dataset behind it. I’d rather see an owner pick the narrower, better-documented tool for the specific gap their vet identifies than buy breadth for its own sake — pair the workup with the modality that actually answers what the bloodwork raised, not the chew with the longest ingredient list.